(Q51412091)

English

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

scientific article published in February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

steatohepatitis

0 references

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Claire Z Larter

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Matthew M Yeh

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Derrick M Van Rooyen

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

John Brooling

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Kamaljit Ghatora

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Geoffrey C Farrell

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

publication date

1 February 2012

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

27

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

341-350

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Animal models of NASH: getting both pathology and metabolic context right

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06939.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2011.06939.X

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/21929649

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51412091&oldid=1988619703"